BioLife Total Stockholder Equity from 2010 to 2025
| BLFS Stock | USD 25.96 0.46 1.80% |
Total Stockholder Equity | First Reported 1989-06-30 | Previous Quarter 325.5 M | Current Value 348.9 M | Quarterly Volatility 126.1 M |
Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 755 K, Selling General Administrative of 38.5 M or Total Revenue of 86.4 M, as well as many indicators such as Price To Sales Ratio of 13.81, Dividend Yield of 0.0014 or PTB Ratio of 3.26. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
BioLife | Total Stockholder Equity |
Latest BioLife Solutions' Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of BioLife Solutions over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. BioLife Solutions' Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLife Solutions' overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
BioLife Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 101,065,450 | |
| Geometric Mean | 33,604,251 | |
| Coefficient Of Variation | 189.53 | |
| Mean Deviation | 154,199,525 | |
| Median | 13,936,317 | |
| Standard Deviation | 191,545,788 | |
| Sample Variance | 36689.8T | |
| Range | 727.7M | |
| R-Value | 0.60 | |
| Mean Square Error | 25101.9T | |
| R-Squared | 0.36 | |
| Significance | 0.01 | |
| Slope | 24,188,021 | |
| Total Sum of Squares | 550346.8T |
BioLife Total Stockholder Equity History
About BioLife Solutions Financial Statements
BioLife Solutions shareholders use historical fundamental indicators, such as Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 348.9 M | 366.4 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.